Merck’s (NYSE:MRK) ~$10B acquisition of Verona Pharma (NASDAQ:VRNA) has been granted approval by the High Court of Justice of England and Wales.
Under terms, MSD, the trade name of Merck outside the US and Canada, will acquire Verona Pharma for $107 per American Depository Share, with each one accounting for eight Verona ordinary shares.
The deal closing is effective Oct. 7. Verona shares will no longer be traded as of market close Monday.
Source: https://seekingalpha.com/news/4502146-merck-acquisition-verona-pharma-approved-court